eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | multiple endocrine neoplasia type 1 |
| Comorbidity | C0221002|primary hyperparathyroidism |
| Sentences | 16 |
| PubMedID- 26191410 | We report here a novel 14 bp deletion men1 mutation in a patient with primary hyperparathyroidism and gastro-duodenal gastrinoma with liver metastasis. |
| PubMedID- 22584724 | Additionally, short-term and medium-term calcium and parathyroid hormone values after parathyroidectomy in patients with primary hyperparathyroidism associated with multiple endocrine neoplasia type 1 are discussed. |
| PubMedID- 22470073 | primary hyperparathyroidism in men1 patients: a cohort study with longterm follow-up on preferred surgical procedure and the relation with genotype. |
| PubMedID- 24251163 | This is first of its kind case which we are reporting here which was later turned out to be multiple endocrine neoplasia type 1 (men 1) syndrome with diagnosis of primary hyperparathyroidism in the same patient in follow-up. |
| PubMedID- 21318141 | primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1. |
| PubMedID- 22584713 | primary hyperparathyroidism associated with multiple endocrine neoplasia type i (hyperparathyroidism/multiple endocrine neoplasia type 1) differs in many aspects from sporadic hyperparathyroidism, which is the most frequently occurring form of hyperparathyroidism. |
| PubMedID- 20972944 | Somatostatin analogues do not affect calcium metabolism in patients with acromegaly and primary hyperparathyroidism [corrected] due to men 1-like syndrome. |
| PubMedID- 26031271 | primary hyperparathyroidism in multiple endocrine neoplasia type i usually affects all parathyroid glands, making focused parathyroidectomy (fp) inappropriate. |
| PubMedID- 20585352 | [10] recently demonstrated the effectiveness of long acting octreotide in the management of men1 patients with primary hyperparathyroidism and duodeno-pancreatic neuroendocrine tumour. |
| PubMedID- 22735224 | Objective: to evaluate frequency, anatomic presentation, and quantities of supernumerary parathyroids glands in patients with primary hyperparathyroidism (hpt1) associated with multiple endocrine neoplasia type 1 (men1), as well as the importance of thymectomy, and the benefits of localizing examinations for those glands. |
| PubMedID- 22508712 | Results: we report two patients with primary hyperparathyroidism due to multiple endocrine neoplasia type 1 who had their first parathyroidectomy at the national institutes of health. |
| PubMedID- 21776381 | Known risk factors for primary hyperparathyroidism include abnormalities of the prad1, men1, and hrpt2 genes that encode for cyclin d1, menin, and parafibromin, respectively. |
| PubMedID- 22584719 | primary hyperparathyroidism in multiple endocrine neoplasia type 1: when to perform surgery. |
| PubMedID- 19650788 | Bone mineral density analysis in patients with primary hyperparathyroidism associated with multiple endocrine neoplasia type 1 after total parathyroidectomy. |
| PubMedID- 22447146 | A novel splice site mutation of the men1 gene identified in a patient with primary hyperparathyroidism. |
| PubMedID- 21713580 | The optimal surgical treatment for primary hyperparathyroidism in men1 patients: a systematic review. |
Page: 1